MENU
+Compare
JNJ
Stock ticker: NYSE
AS OF
Nov 13, 04:59 PM (EDT)
Price
$195.29
Change
+$0.90 (+0.46%)
Capitalization
470.41B

JNJ Johnson & Johnson Forecast, Technical & Fundamental Analysis

Johnson & Johnson is the world's largest and most diverse healthcare firm... Show more

JNJ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for JNJ with price predictions
Nov 12, 2025

Momentum Indicator for JNJ turns positive, indicating new upward trend

JNJ saw its Momentum Indicator move above the 0 level on November 11, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned positive. In of the 82 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for JNJ just turned positive on November 12, 2025. Looking at past instances where JNJ's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where JNJ advanced for three days, in of 349 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 265 cases where JNJ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for JNJ moved out of overbought territory on October 23, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JNJ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

JNJ broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.935) is normal, around the industry mean (9.612). P/E Ratio (18.865) is within average values for comparable stocks, (23.835). Projected Growth (PEG Ratio) (1.055) is also within normal values, averaging (2.037). Dividend Yield (0.026) settles around the average of (0.028) among similar stocks. P/S Ratio (5.141) is also within normal values, averaging (3.560).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. JNJ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
JNJ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

JNJ is expected to report earnings to fall 9.29% to $2.54 per share on January 21

Johnson & Johnson JNJ Stock Earnings Reports
Q4'25
Est.
$2.54
Q3'25
Beat
by $0.04
Q2'25
Beat
by $0.09
Q1'25
Beat
by $0.19
Q4'24
Beat
by $0.02
The last earnings report on October 14 showed earnings per share of $2.80, beating the estimate of $2.76. With 8.63M shares outstanding, the current market capitalization sits at 470.41B.
A.I.Advisor
published Dividends

JNJ paid dividends on September 09, 2025

Johnson & Johnson JNJ Stock Dividends
А dividend of $1.30 per share was paid with a record date of September 09, 2025, and an ex-dividend date of August 26, 2025. Read more...
A.I. Advisor
published General Information

General Information

an investment holding company with interests in health care products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
One Johnson and Johnson Plaza
Phone
+1 732 524-0400
Employees
131900
Web
https://www.jnj.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FDEV33.900.30
+0.89%
Fidelity International Multifactor ETF
TWM33.330.18
+0.54%
ProShares UltraShort Russell2000
VEU73.920.33
+0.45%
Vanguard FTSE All-Wld ex-US ETF
DDWWF5.32N/A
N/A
Dividend Growth Split Corp.
YMAX11.27-0.20
-1.74%
YieldMax Universe Fund Of Option Inc ETF

JNJ and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
+0.29%
PFE - JNJ
59%
Loosely correlated
+1.41%
NVS - JNJ
57%
Loosely correlated
+1.37%
GSK - JNJ
52%
Loosely correlated
-0.70%
BMY - JNJ
44%
Loosely correlated
+0.74%
AMGN - JNJ
43%
Loosely correlated
-0.64%
More